Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Discount Card Rebate Pass-Through Opposed By White House

Executive Summary

The White House is opposed to requiring Medicare prescription drug discount card sponsors to pass through all drug rebates and discounts to the consumer

You may also be interested in...



PBM, Chain Drug Summer Lobbying Focuses On Mail-Order Rx In Medicare

Chain drug stores and PBMs are trying to shape the role of retail and mail-order pharmacy in a Medicare prescription drug benefit through "grassroots" lobbying campaigns during Congress' August recess

PBM, Chain Drug Summer Lobbying Focuses On Mail-Order Rx In Medicare

Chain drug stores and PBMs are trying to shape the role of retail and mail-order pharmacy in a Medicare prescription drug benefit through "grassroots" lobbying campaigns during Congress' August recess

FDA Generic Rx Reforms Contribute To Medicare Budget Squeeze

CBO is predicting only minor savings to the Medicare prescription drug program through Waxman/Hatch reforms contained in the Senate and House versions of the Medicare bill in light of previous reforms announced by FDA

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel